Welcome to the AASLD Media page. Here you’ll find the latest AASLD press releases, information about media registration to AASLD meetings and conferences, and our media policies and guidelines. For inquiries, contact the AASLD media team at media@aasld.org.

Press Releases from The Liver Meeting® 2019

Embargo lifts at 8:00 am ET on Friday, November 8, 2019

Innovative Machine Learning Tool Predicts Who Might Have Non-Alcoholic Steatohepatitis

November 8, 2019
Data from a new study presented this week at The Liver Meeting® found that a machine-learning tool could successfully predict the risk of having non-alcoholic steatohepatitis (NASH) among patients with co-existing diseases.

Read the press release.

All-Oral Direct-Acting Antiviral Treatments Improve Survival in Patients with HCV-Related Hepatocellular Carcinoma

November 8, 2019
Data from a new study presented this week at The Liver Meeting® found that hepatitis C virus-related hepatocellular carcinoma (HCC) patients who achieved sustained virologic response (SVR) – denoting an undetectable level of HCV virus - with any oral direct-acting antiviral (DAA) had over 60-70 percent improvement in five-year survival.

Read the press release.

Kratom, Botanical Supplement with Opioid-Like Activity, May Cause Liver Toxicity and Injury

November 8, 2019
Data from a new study presented this week at The Liver Meeting® found that kratom, a popular and widely available product, may cause liver toxicity and severe liver injury.

Read the press release.

Sexual Transmission of Hepatitis C Low Among HIV-Negative Men Who Have Sex with Men on PrEP

November 8, 2019
Data from a new study presented this week at The Liver Meeting® found fewer new cases of hepatitis C infection (commonly called HCV), despite very high rates of other sexually-transmitted infections, in HIV-negative men who have sex with men who take pre-exposure prophylaxis (PrEP) treatments.

Read the press release.

U.S. Cirrhosis Patients Often Skip or Delay Liver Cancer Surveillance Due to Cost and Lack of Insurance

November 8, 2019
Data from a new study presented this week at The Liver Meeting® found that cirrhosis patients in the U.S. have substantial financial burden, and this is associated with underuse of surveillance – the ongoing collection of health information– for hepatocellular carcinoma (HCC).

Read the press release.

Pregnant Women With Cirrhosis Have Low Levels of Liver Decompensation Within a Year of Delivery

November 8, 2019
Data from a new study presented this week at The Liver Meeting® found that less than two percent of pregnant women with cirrhosis had liver decompensation within one year of delivery, and their odds of decompensation is much lower than non-pregnant women with cirrhosis.

Read the press release.

Could Combining Direct-Acting Antivirals with a Common Cholesterol Medication Open the Door to More Viable Organs for Transplantation?

November 8, 2019
Data from a new study presented this week at The Liver Meeting® found that combination therapy with direct-acting antivirals (DAAs) and ezetimibe ─ a cholesterol medication that has also been shown to block the entry of hepatitis C (or HCV) into the bloodstream of uninfected people ─ given immediately before and seven days after transplantation with an organ from a donor infected with HCV entirely prevented or rapidly cured HCV in the recipient.

Read the press release.

NAFLD Patients Less Likely to Lose Weight, Need More Effective Weight Loss Strategies

November 8, 2019
Data from a new study presented this week at The Liver Meeting® found that obese individuals with nonalcoholic fatty liver disease (NAFLD) were less likely to achieve a medically recommended five percent loss of body weight at three months on a very-low-calorie diet compared to obese counterparts without NAFLD.

Read the press release.

A Healthy Lifestyle May Help Prevent Liver-Related Deaths

November 8, 2019
Data from a new study presented this week at The Liver Meeting® found that a substantial burden of hepatocellular carcinoma (HCC) and cirrhosis-related deaths may be prevented by lifestyle modifications to diet, alcohol use and exercise.

Read the press release.

Global Hepatology Societies Call for Better HCV Testing and Access to Treatment

November 8, 2019
Four societies focused on liver disease research and treatment announced a global call-to-action initiative to simplify hepatitis C testing and treatment. The societies, in partnership with the Clinton Health Access Initiative (CHAI), launched the initiative at The Liver Meeting®.

Read the press release.

Archive of Press Releases

To view press releases from previous years, view the press release archive.